Reconfigurable interconnects in DSM systems: a focus on context switch behavior

Recent advances in the development of reconfigurable optical interconnect technologies allow for the fabrication of low cost and run-time adaptable interconnects in large distributed shared-memory (DSM) multiprocessor machines. This can allow the use of adaptable interconnection networks that alleviate the huge bottleneck present due to the gap between the processing speed and the memory access time over the network. In this paper we have studied the scheduling of tasks by the kernel of the operating system (OS) and its influence on communication between the processing nodes of the system, focusing on the traffic generated just after a context switch. We aim to use these results as a basis to propose a potential reconfiguration of the network that could provide a significant speedup

False friends in the Fanfanyu

In the present article, a remarkable phenomenon is brought to the attention of those interested in early Chinese translations of Buddhist texts: false friends in the Fanfanyu (T54n2130). Baochang's Sanskrit-Chinese lexicon that was compiled as early as 517 AD reveals some curious examples of faux amis. In the present contribution, this case will be illustrated with references from the Shanjian lü piposha (T24n1462), a fifth century Chinese translation of the Samantapāsādikā, Buddhaghosa's commentary on the Pāli Vinaya. The fact that Baochang did not realise that this text was not translated from Sanskrit, inadvertently gave rise to some interesting jeux de mots

The 600 yr eruptive history of Villarrica Volcano (Chile) revealed by annually laminated lake sediments

Lake sediments contain valuable information about past volcanic and seismic events that have affected the lake catchment, and they provide unique records of the recurrence interval and magnitude of such events. This study uses a multilake and multiproxy analytical approach to obtain reliable and high-resolution records of past natural catastrophes from similar to 600-yr-old annually laminated (varved) lake sediment sequences extracted from two lakes, Villarrica and Calafquen, in the volcanically and seismically active Chilean Lake District. Using a combination of micro-X-ray fluorescence (mu XRF) scanning, microfacies analysis, grain-size analysis, color analysis, and magnetic-susceptibility measurements, we detect and characterize four different types of event deposits (lacustrine turbidites, tephra-fall layers, runoff cryptotephras, and lahar deposits) and produce a revised eruption record for Villarrica Volcano, which is unprecedented in its continuity and temporal resolution. Glass geochemistry and mineralogy also reveal deposits of eruptions from the more remote Carran-Los Venados volcanic complex, Quetrupillan Volcano, and the Huanquihue Group in the studied lake sediments. Time-series analysis shows 112 eruptions with a volcanic explosivity index (VEI) >= 2 from Villarrica Volcano in the last similar to 600 yr, of which at least 22 also produced lahars. This significantly expands our knowledge of the eruptive frequency of the volcano in this time window, compared to the previously known eruptive history from historical records. The last VEI >= 2 eruption of Villarrica Volcano occurred in 1991. Based on the last similar to 500 yr, for which we have a complete record from both lakes, we estimate the probability of the occurrence of future eruptions from Villarrica Volcano and statistically demonstrate that the probability of a 22 yr repose period (anno 2013) without VEI >= 2 eruptions is <= 1.7%. This new perspective on the recurrence interval of eruptions and historical lahar activity will help improve volcanic hazard assessments for this rapidly expanding tourist region, and it highlights how lake records can be used to significantly improve historical eruption records in areas that were previously uninhabited

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Background: HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of effective antiviral T-cell responses. In addition, it holds adequate stimuli required for activating antigen presenting cells (APC)s and co-activating specific T-cells (TriMix), including human CD40L, constitutively active TLR4 (caTLR4) and CD70. We propose that in-vivo targeting of dendritic cells (DCs) by direct administration of a HIV mRNA encoding these immune modulating proteins might be an attractive alternative to target DCs in vitro. Methods/design: This is a phase-IIa, randomized, double-blinded, placebo-controlled, multicenter study in chronically HIV-1 infected patients under stable cART. One of the three study arms is randomly allocated to subjects. Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal injection in the inguinal region. Two weeks after the last immunization (week 6) cART is stopped for 12 weeks. The two primary endpoints are: (1) safety and tolerability of intranodal iHIVARNA-01 vaccination compared with TriMix or WFI and (2) induced immunogenicity, i.e., increase in the frequency of HIV-specific T-cell responses between baseline, week 6 and 12 weeks after treatment interruption in iHIVARNA-01-treated patients as compared to the control groups, immunized with TriMix-mRNA or WFI measured by an IFNγ ELISPOT assay. Secondary endpoints include the evaluation of time to viral rebound, plasma viral load (pVL) at w18, the proportion of patients with control of viral load, induction of T-cell responses to new HIV epitopes, polyfunctionality of HIV-specific T-cells, CD8+ T-cell in-vitro HIV suppressive capacity, the effect on viral reservoir (measured by proviral DNA and cell-associated RNA), assessment of viral immune escape by mutation and mRNA expression profiles of host immune genes. Discussion: This trial aims to direct target DC in situ with mRNA encoding HTI and TriMix for co-stimulation. Intranodal injection circumvents laborious DC isolation and handling in the laboratory. The trial extends on the safety results of a phase-I dose-escalating trial. This candidate vaccine could complement or even replace cART for chronic HIV infection and could be applicable to improve the care and cost of HIV infection